Mukund Keshao Gurjar
Chief Tech/Sci/R&D Officer at Emcure Pharmaceuticals Ltd.
Profile
Mukund Keshao Gurjar is currently the Executive Director & Chief Scientific Officer at Emcure Pharmaceuticals Ltd.
He previously worked as a Director at Cipla Ltd.
and as the Deputy Director & Head-Chemistry Division at National Chemical Laboratory.
He was also a Member at Taylor & Francis Group Ltd., American Chemical Society, and Indian Chemical Society.
Dr. Gurjar holds a doctorate degree from the University of London and undergraduate, graduate, and doctorate degrees from Nagpur University.
Mukund Keshao Gurjar active positions
| Companies | Position | Start |
|---|---|---|
Emcure Pharmaceuticals Ltd.
 Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Chief Tech/Sci/R&D Officer | 2013-07-03 |
Former positions of Mukund Keshao Gurjar
| Companies | Position | End |
|---|---|---|
| CIPLA LIMITED | Director/Board Member | 2007-08-26 |
| National Chemical Laboratory | Corporate Officer/Principal | - |
| Indian Chemical Society | Corporate Officer/Principal | - |
Taylor & Francis Group Ltd.
 Taylor & Francis Group Ltd. Publishing: Books/MagazinesConsumer Services Taylor & Francis Group Ltd. (UK) publisher of scholarly journals, books, eBooks, text books and reference works.. It publishes in all areas of the Humanities, Social Sciences, Behavioural Sciences, Science, Technology and Medicine sectors. The company was founded by Richard Taylor in 1798 and is headquartered in Abingdon, the United kingdom. | Corporate Officer/Principal | - |
American Chemical Society
 American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
Training of Mukund Keshao Gurjar
| University of London | Doctorate Degree |
| Nagpur University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CIPLA LIMITED | Health Technology |
| Private companies | 4 |
|---|---|
Taylor & Francis Group Ltd.
Taylor & Francis Group Ltd. Publishing: Books/MagazinesConsumer Services Taylor & Francis Group Ltd. (UK) publisher of scholarly journals, books, eBooks, text books and reference works.. It publishes in all areas of the Humanities, Social Sciences, Behavioural Sciences, Science, Technology and Medicine sectors. The company was founded by Richard Taylor in 1798 and is headquartered in Abingdon, the United kingdom. | Consumer Services |
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Commercial Services |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |
| Indian Chemical Society |
- Stock Market
- Insiders
- Mukund Keshao Gurjar
